Ingenza appoints Steve Jones as its new Chief Financial Officer

Ingenza is pleased to welcome Steve Jones as he takes on the role of Chief Financial Officer (CFO), effective immediately. Steve has over 25 years of industry experience and know-how after holding several senior finance roles across a wide range of business sectors, sizes and ownership models, and will use this expertise to help drive Ingenza’s corporate and financial goals.

Steve is a chartered accountant and fellow of the Institute of Chartered Accountants in England and Wales (ICAEW), and runs a successful consultancy business providing financial advice and resources to SMEs to help maximize their growth potential.

Steve has extensive experience in the life sciences field, including being the finance director of a private pathology laboratory, where he helped to quickly scale up business operations in response to the demands of the COVID-19 pandemic.

He also provides voluntary advice to the Soko Fund, a Scottish charity that aims to improve opportunities for women in Malawi by funding their university education.

“I very much look forward to working closely with the Ingenza team to deliver on its strategic goals and build on the momentum of the company’s already remarkable growth. I have contributed to the success and growth of several SMEs in the life sciences sector, and hope to bring the same positive outcomes to Ingenza in an exciting year of development.”

Steve Jones, CFO at Ingenza

 “Steve’s appointment will allow me to step away from my previous financial and operational responsibilities to focus on accelerating our ambitious new growth strategy, by driving and executing our business development and marketing objectives.”

Jaymin Amin, Chief Business Officer at Ingenza

​​​​​​​“I am excited to welcome Steve to Ingenza as we continue to build a top executive leadership team with the strategic acumen, operational experience and commercial mindset to deliver a strong high growth strategy and accomplish our prioritized corporate goals.”

Dr Ian Fotheringham, Chief Executive Officer at Ingenza

For more information, visit www.ingenza.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ingenza Ltd. (2023, April 03). Ingenza appoints Steve Jones as its new Chief Financial Officer. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20230403/Ingenza-appoints-Steve-Jones-as-its-new-Chief-Financial-Officer.aspx.

  • MLA

    Ingenza Ltd. "Ingenza appoints Steve Jones as its new Chief Financial Officer". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20230403/Ingenza-appoints-Steve-Jones-as-its-new-Chief-Financial-Officer.aspx>.

  • Chicago

    Ingenza Ltd. "Ingenza appoints Steve Jones as its new Chief Financial Officer". News-Medical. https://www.news-medical.net/news/20230403/Ingenza-appoints-Steve-Jones-as-its-new-Chief-Financial-Officer.aspx. (accessed November 21, 2024).

  • Harvard

    Ingenza Ltd. 2023. Ingenza appoints Steve Jones as its new Chief Financial Officer. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20230403/Ingenza-appoints-Steve-Jones-as-its-new-Chief-Financial-Officer.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose